Actively Recruiting

Phase 2
Phase 3
Age: 18Years +
All Genders
NCT06785337

"The Effect of Inhaled Nitroglycerin for COPD Patients

Led by Beni-Suef University · Updated on 2025-01-23

40

Participants Needed

1

Research Sites

43 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

this study aims to investigative the benefits of using nebulized nitroglycerin in improving respiratory functions in patients of late stage COPD

CONDITIONS

Official Title

"The Effect of Inhaled Nitroglycerin for COPD Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients 18 years or older
  • Diagnosis of COPD exacerbation with respiratory failure
  • Evidence of pulmonary hypertension confirmed by echocardiogram (mean pulmonary artery pressure greater than 20 mmHg)
Not Eligible

You will not qualify if you...

  • Severe left ventricular failure
  • Pregnant women
  • Allergy or hypersensitivity to nitroglycerin

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Haram Hospital

Haram, Giza Governorate, Egypt, 12556

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here